Baijin Life Science Issues Profit Warning, Projects FY26 Loss of Up to HK$43.00 Million

Bulletin Express

Jun 29

Baijin Life Science Holdings Limited released a profit warning on 29 June 2026, signalling a substantial deterioration in results for the financial year ended 31 March 2026.

The Group anticipates recording a consolidated net loss not exceeding HK$43.00 million, a sharp reversal from the HK$0.10 million loss reported for the preceding fiscal year ended 31 March 2025.

Management attributes the expected setback to two primary factors:

1. Revenue and gross profit contraction in the jewellery segment. 2. Higher selling expenses incurred by the skincare segment.

These figures stem from the Company’s unaudited management accounts. Final audited results are scheduled for release on 30 June 2026. Shareholders and potential investors are urged to exercise caution when dealing in the Company’s securities until the audited results are published.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/news/1102058932"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1102058932\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1102058932?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-29 23:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1102058932","market":"hk","top_or_hot":-1,"title":"Baijin Life Science Issues Profit Warning, Projects FY26 Loss of Up to HK$43.00 Million","media":"Bulletin Express","content":"<p>Baijin Life Science Holdings Limited released a profit warning on 29 June 2026, signalling a substantial deterioration in results for the financial year ended 31 March 2026.</p>\n<p>The Group anticipates recording a consolidated net loss not exceeding HK$43.00 million, a sharp reversal from the HK$0.10 million loss reported for the preceding fiscal year ended 31 March 2025.</p>\n<p>Management attributes the expected setback to two primary factors:</p>\n<p>1. Revenue and gross profit contraction in the jewellery segment.\n2. Higher selling expenses incurred by the skincare segment.</p>\n<p>These figures stem from the Company’s unaudited management accounts. Final audited results are scheduled for release on 30 June 2026. Shareholders and potential investors are urged to exercise caution when dealing in the Company’s securities until the audited results are published.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Baijin Life Science Issues Profit Warning, Projects FY26 Loss of Up to HK$43.00 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBaijin Life Science Issues Profit Warning, Projects FY26 Loss of Up to HK$43.00 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-29 23:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Baijin Life Science Holdings Limited released a profit warning on 29 June 2026, signalling a substantial deterioration in results for the financial year ended 31 March 2026.</p>\n<p>The Group anticipates recording a consolidated net loss not exceeding HK$43.00 million, a sharp reversal from the HK$0.10 million loss reported for the preceding fiscal year ended 31 March 2025.</p>\n<p>Management attributes the expected setback to two primary factors:</p>\n<p>1. Revenue and gross profit contraction in the jewellery segment.\n2. Higher selling expenses incurred by the skincare segment.</p>\n<p>These figures stem from the Company’s unaudited management accounts. Final audited results are scheduled for release on 30 June 2026. Shareholders and potential investors are urged to exercise caution when dealing in the Company’s securities until the audited results are published.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01466","symbol_name":"佰金生命科学","start_time":0,"source_url":"","article_id":"1102058932","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1102058932","pubTimestamp":1782745671,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Baijin Life Science Holdings Limited released a profit warning on 29 June 2026, signalling a substantial deterioration in results for the financial year ended 31 March 2026. The Group anticipates...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01466":"佰金生命科学"},"translate_title":"百金生命科学发布盈利预警预计26财年亏损高达4300万港元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01466":1},"content_text":"Baijin Life Science Holdings Limited released a profit warning on 29 June 2026, signalling a substantial deterioration in results for the financial year ended 31 March 2026.\nThe Group anticipates recording a consolidated net loss not exceeding HK$43.00 million, a sharp reversal from the HK$0.10 million loss reported for the preceding fiscal year ended 31 March 2025.\nManagement attributes the expected setback to two primary factors:\n1. Revenue and gross profit contraction in the jewellery segment.\n2. Higher selling expenses incurred by the skincare segment.\nThese figures stem from the Company’s unaudited management accounts. Final audited results are scheduled for release on 30 June 2026. Shareholders and potential investors are urged to exercise caution when dealing in the Company’s securities until the audited results are published.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-2","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}